Aurinia Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$73,468
$70,008
$62,465
$59,867
Gross Profit
64,964
62,893
53,891
54,315
EBITDA
36,827
28,137
30,272
7,181
EBIT
31,962
23,273
25,416
2,319
Net Income
31,551
21,513
23,344
1,429
Net Change In Cash
73,468
70,008
62,465
59,867
Free Cash Flow
44,384
44,143
1,283
30,058
Cash
73,189
53,002
66,428
83,433
Basic Shares
136,008
143,199
138,917
147,675

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$235,133
$175,513
$134,030
$45,605
Gross Profit
206,885
161,365
128,366
44,514
EBITDA
31,728
-63,047
-108,764
-177,445
EBIT
12,283
-74,694
-111,470
-180,206
Net Income
5,752
-78,020
-108,180
-180,966
Net Change In Cash
235,133
175,513
134,030
45,605
Cost of Revenue
-40,450
Free Cash Flow
44,107
-34,179
-79,821
-159,193
Cash
83,433
48,875
94,172
231,900
Basic Shares
146,194
143,236
141,915
129,369

Earnings Calls

QuarterEPS
2025-09-30
$0.23
2025-06-30
$0.16
2025-03-31
$0.16
2024-12-31
$0.01